Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-00-000094
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
2
Group Members
E.M. WARBURG, PINCUS & CO., LLCWARBURG PINCUS INVESTORS LPWARBURG, PINCUS & CO.WARBURG, PINCUS CAPITAL PARTNERS LIQUIDATING TRUSTWARBURG, PINCUS INVESTORS, L.P.

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING ON SCHEDULE 13G SC 13G 18129
2 JOINT FILING AGREEMENT EX-99.1 2355
  Complete submission text file 0000899140-00-000094.txt   22685
Mailing Address
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Subject) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42340 | Film No.: 542639
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 466 LEXINGTON AVENUE NEW YORK NY 10017-3147
Business Address 466 LEXINGTON AVENUE NEW YORK NY 10017-3147 2128780600
WARBURG PINCUS INVESTORS LP (Filed by) CIK: 0000929658 (see all company filings)

EIN.: 133549187 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000